ArticleJournal of clinical medicine2024

Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis: An Italian Multicenter Analysis.

Elena Pezzolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.